Colorado Biofuels Firm Raises $34M For Biorefinery

Feb 2 2009 | 9:02am ET

ZeaChem Inc., a Colorado-based developer of biorefineries for the conversion of biomass into fuels and chemicals, has raised $34 million in initial Series B financing for the construction of its first cellulosic biorefinery.

The funding round was co-led by venture capital investors Globespan Capital Partners and PrairieGold Venture Partners with follow-on investment by MDV-Mohr Davidow Ventures, Firelake Capital and Valero Energy Corporation, the largest petroleum refiner in the United States.

ZeaChem is developing a cellulose-based green fuels and chemicals biorefinery platform that converts renewable non-food biomass into market-competitive products such as ethanol.

“ZeaChem has made tremendous progress over the past year towards commercializing its hybrid cellulosic ethanol technology,” said James Imbler, ZeaChem president and chief executive officer. “Securing such funding in a challenging economy – from industry leaders in both energy and venture capital –  is testament to the value of ZeaChem's third-generation cellulosic ethanol platform.”

ZeaChem will begin construction of its first plant in 2009.


In Depth

Change In 'Accredited Investor' Definition Could Hurt Crowdfunding Space

Jul 25 2014 | 8:14am ET

The Securities and Exchange Commission is considering changes to its 30-year-old...

Lifestyle

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Guest Contributor

The Truth About Track Record Portability

Jul 24 2014 | 5:55am ET

The number of private funds converting to mutual funds has increased significantly...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note